Manufacturing cell therapies is technically and financially
demanding; as a result, despite therapy developers gradually strengthening
their in-house expertise, they are also becoming increasingly reliant on
contract service providers
Roots Analysis is pleased to announce the publication of its recent
study, titled, “Cell Therapy Manufacturing Market (3rd
Edition), 2019 - 2030.”
The report features an extensive study of the current
market landscape and future opportunities associated with cell therapy
manufacturing. It focuses on both contract manufacturers, as well as developers
with in-house manufacturing facilities, offering in-depth analyses of the
various business entities that are engaged in this domain, across different
global regions. Amongst other elements, the report includes:
§
An analysis of the various expansion initiatives undertaken
by service providers, in order to augment their respective cell therapy
manufacturing capabilities, over the period 2015-2019.
§
An analysis of the recent partnerships focused on the
manufacturing of cell-based therapies, which have been established in the period
2014-2019.
§
Informed estimates of the annual commercial and clinical
demand for cell therapies, in terms of number of cells produced and area
dedicated to manufacturing.
§
An estimate of the overall, installed capacity for
manufacturing cell-based therapies based on information reported by industry
stakeholders in the public domain A competitiveness analysis of biological
targets, featuring insightful pictorial summaries and representations.
§
A detailed analysis of the various factors that are likely
to influence the pricing of cell-based therapies, featuring different models /
approaches that may be adopted by manufacturers while deciding the prices of
their proprietary offerings.
§
A qualitative
analysis, highlighting the various factors that need to be taken into
consideration by cell therapy developers while deciding whether to manufacture
their respective products in-house or engage the services of a CMO.
§
An elaborate discussion on the role of automation
technologies in improving current manufacturing methods.
§
A discussion on cell
therapy manufacturing regulations across various geographies, including North
America, Europe, and Asia Pacific.
§
Elaborate profiles of key players (industry and
non-industry) that offer contract manufacturing services.
§
A discussion on affiliated trends, key drivers and
challenges, which are likely to impact the industry’s evolution, under a
comprehensive SWOT framework.
§
A detailed market forecast, featuring analysis of the
current and projected future opportunity across key market segments (listed
below)
§ Type
of therapy
§ T-cell
therapies (CAR-T therapies, TCR therapies, TIL therapies)
§ Dendritic
cell therapies
§ Tumor
cell therapies
§ NK
cell therapies
§ Stem
cell therapies
§
Source of cells
§
Autologous
§
Allogeneic
§ Scale
of operation
§
Clinical
§
Commercial
§ Purpose
of manufacturing
§
Contract manufacturing
§
In-house manufacturing
§ Key
geographical regions
§
North America
§
Europe
§
Asia Pacific
§
Rest of the world
Key
companies covered in the report
§
BioNTech Innovative Manufacturing Services
§
Cell Therapies
§
Cell and Gene Therapy Catapult
§
Center for Cell and Gene Therapy, Baylor College of
Medicine
§
Centre for Cell Manufacturing Ireland, National University
of Ireland
§
Clinical Cell and Vaccine Production Facility, University
of Pennsylvania
§
Cognate BioServices
§
FUJIFILM
§
Guy’s and St. Thomas’ GMP Facility, Guy’s Hospital
§
Hitachi Chemical
§
KBI Biopharma
§
Laboratory for Cell and Gene Medicine, Stanford University
§
Lonza
§
MaSTherCell
§
MEDINET
§
Molecular and Cellular Therapeutics, University of
Minnesota
§
Newcastle Cellular Therapies Facility, Newcastle University
§
Nikon CeLL innovation
§
Rayne Cell Therapy Suite, King’s College London
§
Roslin Cell Therapies
§
Scottish National Blood Transfusion Services Cellular
Therapy Facility, Scottish Centre for Regenerative Medicine
§
Sydney Cell and Gene Therapy
§
WuXi Advanced Therapies
For additional
details, please visit
https://www.rootsanalysis.com/reports/view_document/cell-therapy-manufacturing/285.html
or
email sales@rootsanalysis.com
You may also be
interested in the following titles:
1.
Cell and Advanced
Therapies Supply Chain Management Market, 2019-2030
2.
RNAi Therapeutics
Market (2nd Edition), 2019 – 2030
3.
Gene Therapy Market
(3rd Edition), 2019 – 2030
4.
Stem Cell Therapy
Contract Manufacturing Market, 2019-2030
Contact:
Gaurav Chaudhary
+1 (415) 800 3415
Gaurav.Chaudhary@rootsanalysis.com
